Laser Scanning Cytometry for the Detection of Neoplasia in Urologic Cytology Specimens

Cancer

Volumn 102, Issue 2, 2004, Pages 115-123

  Foster, Sarah S ^a   Leiman, Gladwyn ^a,b   Schwarz, Janet E ^a   St John, Timothy ^b   Beatty, Barbara G ^a,c  

^a UNIVERSITY OF VERMONT   (United States)

^b FLETCHER ALLEN HEALTH CARE   (United States)

^c UNIVERSITY OF VERMONT COLLEGE OF MEDICINE   (United States)

Author keywords

Cytology; DNA ploidy; Laser scanning cytometry; Urothelial atypia; Urothelial carcinoma

Indexed keywords

PROPIDIUM IODIDE;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOMETRY; DIAGNOSTIC ACCURACY; FLUORESCENCE; HISTOGRAM; HUMAN; HUMAN CELL; HUMAN TISSUE; LASER MICROSCOPY; PLOIDY; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; TUMOR DIAGNOSIS; UROGENITAL TRACT TUMOR;

ANEUPLOIDY; GLYCOSIDES; HUMANS; IMAGE CYTOMETRY; LASERS; MALE; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; UROLOGIC NEOPLASMS;

EID: 1842853108     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20112     Document Type: Article

References (35)

1. Ho KJ, Kuo SH. Urinary beta-glucuronidase activity as an initial screening test for urinary tract malignancy in high risk patients. Cancer. 1995;76:473-478.
2. Slaton J, Dinney C, Veltri R, et al. Deoxyribonucleic acid ploidy enhances the cytological prediction of recurrent transitional cell carcinoma of the bladder. J Urol. 1997;158:806-811.
3. Planz B, Synek C, Robben J, Bocking A, Marberger M. Diagnostic accuracy of DNA image cytometry and urinary cytology with cells from voided urine in the detection of bladder cancer. Urology. 2000;56:782-786.
4. Dalquen P, Kleiber B, Grilli B, Herzog M, Bubendorf L, Oberholzer M. DNA image cytometry and fluorescence in situ hybridization for noninvasive detection of urothelial tumors in voided urine. Cancer (Cancer Cytopathol). 2002;96:374-379.
5. Katz R, Sinkre P, Zhang H, Kidd L, Johnston D. Clinical significance of negative and equivocal urinary bladder cytology alone and in combination with DNA image analysis and cystoscopy. Cancer (Cancer Cytopathol). 1997;81:354-364.
6. Lipponen P, Eskelinen M, Nordling S. Progression and survival in transitional cell bladder cancer: a comparison of established prognostic factors, S-phase fraction and DNA ploidy. Eur J Cancer. 1991;27:877-881.
7. Corrado F, Ferri C, Mannini D, et al. Transitional cell carcinoma of the upper urinary tract: evaluation of prognostic factors by histopathology and flow cytometric analysis. J Urol. 1991;145:1159-1163.
8. Holmang S, Andius P, Hedelin H, Wester K, Busch C, Johansson S. Stage progression in TA papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy. J Urol. 2001;165:1124-1130.
9. Kawamura K, Tanaka T, Ikeda R, Fujikawa-Yamamoto K, Suzuki K. DNA ploidy analysis of urinary tract epithelial tumors by laser scanning cytometry. Anal Quant Cytol Hisrol. 1999;22:26-30.
10. Wojcik E, Saraga S, Jin J, Hendricks J. Application of laser scanning cytometry for evaluation of DNA ploidy in routine cytologic specimens. Diagn Cytopathol. 2000;24:200-205.
11. Takes R, van Blommestein R, van Krieken H, Baatenburg de Jong R, Hermans J, Cornelisse C. DNA ploidy status as a prognostic marker and predictor of lymph node metastasis in laryngeal carcinoma. Ann Otol Rhinol Laryngol. 2002;111:1015-1020.
12. Wheeless L, Badalament R, deVere White R, Fradet Y, Tribukait B. Consensus review of the clinical utility of DNA cytometry in bladder cancer. Cytometry. 1993;14:478-481.
13. Fuhr J. Flow cytometry and cytopathology: analysis of fine-needle aspirates, effusions, and urology specimens. Pathol Annu. 1994;29:211-231.
14. Atkin N. Frequency of hyperdiploid chromosome complements in endometrioid tumors of the endometrium whereas similar tumors in the ovary tend to show hypodiploidy: a significant difference that may not be distinguishable by flow cytometry of DNA content. Cytogenet Genome Res. 2002;97:39-42.
15. Hendricks J, Wojcik E. Quantitative cytology and histology by laser scanning cytometry. Clin Immunol. 1998;18:21-32.
16. Wojcik E, Brownlie R, Bassler T, Miller M. A potential cause of abnormal DNA ploidy results in urine specimens. Anal Quant Cytol Histol. 2000;22:411-415.
17. Kamentsky LA, Kamentsky LD. Microscope-based multiparameter laser scanning cytometer yielding data comparable to flow cytometry data. Cytometry. 1991;12:381-387.
18. Deptala A, Bedner E, Darzynkiewicz Z. Unique analytical capabilities of laser scanning cytometry (LSC) that complement flow cytometry. Folia Histochem Cytobiol. 2001;39:87-89.
19. Darzynkiewicz Z, Bedner E, Li X, Gorczyca W, Melamed M. Laser-scanning cytometry: a new instrumentation with many applications. Exp Cell Res. 1999;249:1-12.
20. Martin-Reay D, Kamentsky LA, Weinberg D, Hollister K, Cibas E. Evaluation of a new slide-based laser scanning cytometer for DNA analysis of tumors. Anat Pathol. 1993;102:432-437.
21. Sasaki K, Kurose A, Miura Y, Sato T, Ikeda E. DNA ploidy analysis by laser scanning cytometry (LSC) in colorectal cancers and comparison with flow cytometry. Cytometry. 1996;23:106-109.
22. Gorczyca W, Sarode V, Juan G, Melamed M, Darzynkiewicz Z. Laser scanning cytometric analysis of cyclin B1 in primary human malignancies. Mod Pathol. 1997;10:457-462.
23. Hashimoto Y, Oga A, Okami K, Imate Y, Yamaskita Y, Sasaki K. Relationship between cytogenetic aberrations by CGH coupled with tissue miscrodissection and DNA ploidy by laser scanning cytometry in head and neck squamous cell carcinoma. Cytometry. 2000;40:161-166.
24. Gorczyca W, Darzynkiewicz Z, Melamed M. Laser scanning cytometry in pathology of solid tumors. Acta Cytol. 1997;41:98-108.
25. Mocellin S, Fetsch P, Abati A, et al. Laser scanning cytometry evaluation of MART-1, gp 100, and HLA-A2 expression in melanoma metastases. J Immunother. 2001;24:447-458.
26. Clatch R, Foreman J, Walloch J. Simplified immunophenotypic analysis by laser scanning cytometry. Cytometry. 1998;34:3-16.
27. Bittard H, Lamy B, Billery C. Clinical evaluation of cell deoxyribonucleic acid content measured by flow cytometry in bladder cancer. J Urol. 1996;155:1887-1891.
28. deVere White RW, Deitch AD. Evaluation of DNA flow cytometry as a screening test for bladder cancer. J Cell Biochem Suppl. 1992;161:80-84.
29. Bakhos R, Shankey TV, Flanigan RC, Fisher S, Wojcik EM. Comparative analysis of DNA flow cytometry and cytology of bladder washings: review of discordant cases. Diagn Cytopathol. 2000;22:65-69.
30. Shabaik AS, Pow-Sang JM, Lockhart J, Nicosia SV. Role of DNA image cytometry in the follow-up of patients with urinary tract transitional cell carcinoma. Anal Quant Cytol Histol. 1993;15:115-123.
31. Halling K, King W, Sokolova I, et al. A comparison of cytology and fluorescence in situ hybridization for the detection of urothelial carcinoma. J Urol. 2000;154:1768-1775.
32. Sokolova I, Halling K, Jenkins R, et al. The development of a multitarget, multicolor fluorescence in situ hybridization assay for the detection of urothelial carcinoma in urine. J Mol Diagn. 2000;2:116-123.
33. Bubendorf L, Grilli B, Sauter G, Mihatsch M, Gasser T, Dalquen P. Multiprobe FISH for enhanced detection of bladder cancer in voided urine specimens and bladder washings. Am J Clin Pathol. 2001;116:79-86.
34. Jiang F, Katz RL. Use of interphase fluorescence in situ hybridization as a powerful diagnostic tool in cytology. Diagn Mol Pathol. 2002;11:47-57.
35. Sarosdy MF, Schellhammer P, Bokinsky G, et al. Clinical evaluation of a multi-target fluorescent in situ hybridization assay for detection of bladder cancer. J Urol. 2002;168:1950-1954.